PDCD1 and neoplasm: A study on head and neck squamous cell carcinoma (HNSCC) found that PD-1 blockade significantly reduced tumor growth in the HNSCC mouse model, along with a significant reduction in MDSCs and TAMs in immune organs and tumors [70, 71].